

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 5.95891958 |
| 2 | cytidine metabolic process (GO:0046087) | 5.95891958 |
| 3 | cytidine catabolic process (GO:0006216) | 5.95891958 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.69548815 |
| 5 | NADH metabolic process (GO:0006734) | 5.47673017 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 5.44928820 |
| 7 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.88046365 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.74313223 |
| 9 | respiratory electron transport chain (GO:0022904) | 4.59331919 |
| 10 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.57125706 |
| 11 | cellular response to zinc ion (GO:0071294) | 4.52946492 |
| 12 | electron transport chain (GO:0022900) | 4.46445715 |
| 13 | biotin metabolic process (GO:0006768) | 4.44037915 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 4.34732280 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.32792821 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25087459 |
| 17 | regulation of cofactor metabolic process (GO:0051193) | 4.19262333 |
| 18 | regulation of coenzyme metabolic process (GO:0051196) | 4.19262333 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 4.03058142 |
| 20 | proteasome assembly (GO:0043248) | 3.94992306 |
| 21 | succinate metabolic process (GO:0006105) | 3.93684556 |
| 22 | ubiquinone biosynthetic process (GO:0006744) | 3.93422976 |
| 23 | quinone biosynthetic process (GO:1901663) | 3.93422976 |
| 24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.86901176 |
| 25 | ATP synthesis coupled proton transport (GO:0015986) | 3.86901176 |
| 26 | branched-chain amino acid catabolic process (GO:0009083) | 3.82048935 |
| 27 | chaperone-mediated protein transport (GO:0072321) | 3.81040828 |
| 28 | pseudouridine synthesis (GO:0001522) | 3.78758219 |
| 29 | valine metabolic process (GO:0006573) | 3.69101223 |
| 30 | rRNA modification (GO:0000154) | 3.68316201 |
| 31 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.63592716 |
| 32 | carnitine shuttle (GO:0006853) | 3.62562305 |
| 33 | branched-chain amino acid metabolic process (GO:0009081) | 3.59411701 |
| 34 | inner mitochondrial membrane organization (GO:0007007) | 3.55627090 |
| 35 | ubiquinone metabolic process (GO:0006743) | 3.53881024 |
| 36 | DNA strand elongation (GO:0022616) | 3.52091745 |
| 37 | oxidative phosphorylation (GO:0006119) | 3.48240994 |
| 38 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44701243 |
| 39 | carnitine transmembrane transport (GO:1902603) | 3.42058936 |
| 40 | amino-acid betaine transport (GO:0015838) | 3.37861168 |
| 41 | carnitine transport (GO:0015879) | 3.37861168 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.37213727 |
| 43 | axon ensheathment in central nervous system (GO:0032291) | 3.24824337 |
| 44 | central nervous system myelination (GO:0022010) | 3.24824337 |
| 45 | fatty acid transmembrane transport (GO:1902001) | 3.21018414 |
| 46 | regulation of mitochondrial translation (GO:0070129) | 3.20413581 |
| 47 | protein complex biogenesis (GO:0070271) | 3.19828410 |
| 48 | rRNA methylation (GO:0031167) | 3.19561134 |
| 49 | maturation of 5.8S rRNA (GO:0000460) | 3.18290820 |
| 50 | lipid particle organization (GO:0034389) | 3.16553370 |
| 51 | ribosomal small subunit biogenesis (GO:0042274) | 3.14077254 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.13077044 |
| 53 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.13077044 |
| 54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.13077044 |
| 55 | mitochondrial RNA metabolic process (GO:0000959) | 3.11595557 |
| 56 | DNA replication checkpoint (GO:0000076) | 3.09421375 |
| 57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08247381 |
| 58 | acetyl-CoA metabolic process (GO:0006084) | 3.05542530 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05412966 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05412966 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 3.01632905 |
| 62 | acyl-CoA biosynthetic process (GO:0071616) | 3.00998454 |
| 63 | thioester biosynthetic process (GO:0035384) | 3.00998454 |
| 64 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.00589126 |
| 65 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.00589126 |
| 66 | telomere maintenance via recombination (GO:0000722) | 2.99619392 |
| 67 | triglyceride catabolic process (GO:0019433) | 2.99079347 |
| 68 | rRNA processing (GO:0006364) | 2.97577788 |
| 69 | cytochrome complex assembly (GO:0017004) | 2.92699615 |
| 70 | respiratory chain complex IV assembly (GO:0008535) | 2.92410899 |
| 71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.90822859 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88449259 |
| 73 | negative regulation of ligase activity (GO:0051352) | 2.88449259 |
| 74 | triglyceride biosynthetic process (GO:0019432) | 2.87820071 |
| 75 | ribosome assembly (GO:0042255) | 2.86147141 |
| 76 | tricarboxylic acid metabolic process (GO:0072350) | 2.85678579 |
| 77 | rRNA metabolic process (GO:0016072) | 2.85274810 |
| 78 | transcription from mitochondrial promoter (GO:0006390) | 2.85145640 |
| 79 | ribosome biogenesis (GO:0042254) | 2.83573313 |
| 80 | response to epinephrine (GO:0071871) | 2.83284934 |
| 81 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.82395525 |
| 82 | regulation of sulfur metabolic process (GO:0042762) | 2.82308722 |
| 83 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.82288490 |
| 84 | purine nucleobase biosynthetic process (GO:0009113) | 2.81598564 |
| 85 | cellular response to epinephrine stimulus (GO:0071872) | 2.81461266 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.81312342 |
| 87 | nucleobase biosynthetic process (GO:0046112) | 2.81308786 |
| 88 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.81009826 |
| 89 | brown fat cell differentiation (GO:0050873) | 2.80851862 |
| 90 | quaternary ammonium group transport (GO:0015697) | 2.80695615 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 2.79747397 |
| 92 | purine nucleotide salvage (GO:0032261) | 2.76937209 |
| 93 | fatty acid catabolic process (GO:0009062) | 2.76778933 |
| 94 | response to peptidoglycan (GO:0032494) | 2.75733886 |
| 95 | glycerol metabolic process (GO:0006071) | 2.74587437 |
| 96 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.72773716 |
| 97 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.71916615 |
| 98 | GMP metabolic process (GO:0046037) | 2.71209899 |
| 99 | IMP biosynthetic process (GO:0006188) | 2.70769848 |
| 100 | ribosomal small subunit assembly (GO:0000028) | 2.70206093 |
| 101 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.70145997 |
| 102 | mitotic recombination (GO:0006312) | 2.69911776 |
| 103 | coenzyme A biosynthetic process (GO:0015937) | 2.69832321 |
| 104 | peptidyl-histidine modification (GO:0018202) | 2.69256952 |
| 105 | cellular response to interleukin-15 (GO:0071350) | 2.68736378 |
| 106 | DNA replication initiation (GO:0006270) | 2.68705050 |
| 107 | mitochondrial transport (GO:0006839) | 2.68327484 |
| 108 | establishment of protein localization to mitochondrion (GO:0072655) | 2.68270609 |
| 109 | maturation of SSU-rRNA (GO:0030490) | 2.67896509 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 2.66660118 |
| 111 | fatty acid oxidation (GO:0019395) | 2.64973634 |
| 112 | establishment of mitochondrion localization (GO:0051654) | 2.64093247 |
| 113 | tRNA methylation (GO:0030488) | 2.62862732 |
| 114 | lipid oxidation (GO:0034440) | 2.61911587 |
| 115 | positive regulation of mitochondrial fission (GO:0090141) | 2.60746246 |
| 116 | adaptation of signaling pathway (GO:0023058) | 2.60572917 |
| 117 | DNA deamination (GO:0045006) | 2.60536856 |
| 118 | protein localization to mitochondrion (GO:0070585) | 2.58140261 |
| 119 | acylglycerol biosynthetic process (GO:0046463) | 2.57885570 |
| 120 | neutral lipid biosynthetic process (GO:0046460) | 2.57885570 |
| 121 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.57493856 |
| 122 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.57415415 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.56494812 |
| 124 | cellular component biogenesis (GO:0044085) | 2.56250024 |
| 125 | termination of RNA polymerase III transcription (GO:0006386) | 2.55775876 |
| 126 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.55775876 |
| 127 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.55746806 |
| 128 | creatine metabolic process (GO:0006600) | 2.55234583 |
| 129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55204381 |
| 130 | regulation of fatty acid oxidation (GO:0046320) | 2.53992527 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.53904073 |
| 132 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.53679951 |
| 133 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.53679951 |
| 134 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.53679951 |
| 135 | protein targeting to mitochondrion (GO:0006626) | 2.53404156 |
| 136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52871172 |
| 137 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52871172 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 2.52196956 |
| 139 | iron-sulfur cluster assembly (GO:0016226) | 2.52196956 |
| 140 | regulation of B cell differentiation (GO:0045577) | 2.51713970 |
| 141 | tRNA modification (GO:0006400) | 2.51466901 |
| 142 | aerobic respiration (GO:0009060) | 2.51102370 |
| 143 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.50663470 |
| 144 | response to interleukin-15 (GO:0070672) | 2.50422765 |
| 145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.50216997 |
| 146 | serine transport (GO:0032329) | 2.49873038 |
| 147 | nucleoside salvage (GO:0043174) | 2.49558802 |
| 148 | proton transport (GO:0015992) | 2.49258798 |
| 149 | hydrogen transport (GO:0006818) | 2.49240677 |
| 150 | regulation of chronic inflammatory response (GO:0002676) | 2.49120118 |
| 151 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.49013441 |
| 152 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48799901 |
| 153 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48799901 |
| 154 | deoxyribonucleotide catabolic process (GO:0009264) | 2.48540333 |
| 155 | formation of translation preinitiation complex (GO:0001731) | 2.47662730 |
| 156 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47417710 |
| 157 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.47009137 |
| 158 | neutral lipid catabolic process (GO:0046461) | 2.46549062 |
| 159 | acylglycerol catabolic process (GO:0046464) | 2.46549062 |
| 160 | regulation of mitochondrial fission (GO:0090140) | 2.45788002 |
| 161 | nucleotide salvage (GO:0043173) | 2.45036944 |
| 162 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.44532591 |
| 163 | ncRNA processing (GO:0034470) | 2.44051487 |
| 164 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.43961095 |
| 165 | deoxyribose phosphate catabolic process (GO:0046386) | 2.43662189 |
| 166 | telomere maintenance via telomere lengthening (GO:0010833) | 2.42391263 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.41837059 |
| 168 | alditol metabolic process (GO:0019400) | 2.40680288 |
| 169 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.40469603 |
| 170 | purine-containing compound salvage (GO:0043101) | 2.39269832 |
| 171 | positive regulation of ligase activity (GO:0051351) | 2.39246339 |
| 172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39134991 |
| 173 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.39111784 |
| 174 | lipid storage (GO:0019915) | 2.38810888 |
| 175 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.38304097 |
| 176 | B cell mediated immunity (GO:0019724) | 2.37806072 |
| 177 | tRNA processing (GO:0008033) | 2.36859889 |
| 178 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.36800951 |
| 179 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.36550513 |
| 180 | mitochondrial fusion (GO:0008053) | 2.36529059 |
| 181 | positive regulation of B cell differentiation (GO:0045579) | 2.36359326 |
| 182 | RNA methylation (GO:0001510) | 2.36324084 |
| 183 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.36035570 |
| 184 | kinetochore organization (GO:0051383) | 2.35965192 |
| 185 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.35955182 |
| 186 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.35955182 |
| 187 | kinetochore assembly (GO:0051382) | 2.35801975 |
| 188 | glycine transport (GO:0015816) | 2.35442017 |
| 189 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.34508380 |
| 190 | regulation of B cell apoptotic process (GO:0002902) | 2.33821885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.61940368 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.52449271 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.54083911 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.31209008 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22099719 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.18104199 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12660065 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.85288872 |
| 9 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74749151 |
| 10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65159775 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61749808 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.55488636 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52119728 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34446555 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.33903326 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25403382 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.15340924 |
| 18 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.13605253 |
| 19 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02804665 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00705118 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.99287958 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.96403932 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96049289 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.91721167 |
| 25 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89178989 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89063669 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.88660098 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.82738362 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81300646 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80826572 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80690774 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79769597 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.77837247 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76211084 |
| 35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75396619 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67631184 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65103342 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62781935 |
| 39 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62306383 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.61033756 |
| 41 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.60406488 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59346176 |
| 43 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58693677 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56655491 |
| 45 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.55410656 |
| 46 | * MYC_22102868_ChIP-Seq_BL_Human | 1.54834676 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.51612299 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51013650 |
| 49 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.50573303 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48277306 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48137401 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47851229 |
| 53 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46774376 |
| 54 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45877665 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42621935 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40747282 |
| 57 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39753793 |
| 58 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37453640 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36899982 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36446188 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36018703 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35918848 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35745004 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35224071 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34914520 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33996768 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31958049 |
| 68 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31864201 |
| 69 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30572450 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29975987 |
| 71 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29325285 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24274432 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24239657 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.22296011 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22152143 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.19891956 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19877340 |
| 78 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19632301 |
| 79 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.17485316 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16166129 |
| 81 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15337818 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14679615 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13865946 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13545304 |
| 85 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13453899 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13300707 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12384074 |
| 88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09920885 |
| 89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08479986 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06971804 |
| 91 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05997145 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05157871 |
| 93 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.04117427 |
| 94 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03656389 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02941059 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01965977 |
| 97 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01103545 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00782446 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00743763 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99650396 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99128328 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99124338 |
| 103 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97518680 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96084987 |
| 105 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96065771 |
| 106 | P300_27268052_Chip-Seq_Bcells_Human | 0.95560183 |
| 107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94546488 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93067505 |
| 109 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92391551 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91800922 |
| 111 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90530089 |
| 112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90354255 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90321955 |
| 114 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90113641 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89700236 |
| 116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89364975 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89105384 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88914135 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88870385 |
| 120 | * MYB_26560356_Chip-Seq_TH2_Human | 0.88472400 |
| 121 | MAF_26560356_Chip-Seq_TH1_Human | 0.88207694 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87835794 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87093747 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.85854483 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85555717 |
| 126 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85287903 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85006843 |
| 128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83163351 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83016617 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82912810 |
| 131 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.82866191 |
| 132 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81244306 |
| 133 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79280645 |
| 134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79101639 |
| 135 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78540171 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78420294 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77940242 |
| 138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77757263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.41905562 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.67915770 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.34027455 |
| 4 | MP0003646_muscle_fatigue | 3.11818615 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.03432469 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.01366642 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.80975063 |
| 8 | MP0008058_abnormal_DNA_repair | 2.70428224 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.61370900 |
| 10 | * MP0006036_abnormal_mitochondrial_physio | 2.57217462 |
| 11 | MP0005387_immune_system_phenotype | 2.42163282 |
| 12 | MP0001790_abnormal_immune_system | 2.42163282 |
| 13 | MP0008057_abnormal_DNA_replication | 2.41433663 |
| 14 | MP0009840_abnormal_foam_cell | 2.37670955 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.37517348 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.37283816 |
| 17 | MP0004130_abnormal_muscle_cell | 2.25519174 |
| 18 | MP0003077_abnormal_cell_cycle | 2.21264709 |
| 19 | MP0001800_abnormal_humoral_immune | 2.18644069 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.17861280 |
| 21 | MP0006082_CNS_inflammation | 2.16501616 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.09962242 |
| 23 | MP0003303_peritoneal_inflammation | 2.09129879 |
| 24 | MP0003880_abnormal_central_pattern | 1.93545052 |
| 25 | MP0005671_abnormal_response_to | 1.92574493 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.90778587 |
| 27 | MP0003436_decreased_susceptibility_to | 1.87211194 |
| 28 | MP0001905_abnormal_dopamine_level | 1.80211580 |
| 29 | MP0005535_abnormal_body_temperature | 1.79485580 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.76142973 |
| 31 | MP0002971_abnormal_brown_adipose | 1.73294355 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.71441584 |
| 33 | MP0001873_stomach_inflammation | 1.71408633 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.68921429 |
| 35 | MP0000920_abnormal_myelination | 1.68692894 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.65104361 |
| 37 | MP0000685_abnormal_immune_system | 1.64387369 |
| 38 | MP0001529_abnormal_vocalization | 1.63200198 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.61724694 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.59025214 |
| 41 | MP0009278_abnormal_bone_marrow | 1.58874345 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.56823720 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.56823720 |
| 44 | MP0004043_abnormal_pH_regulation | 1.54335326 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.53879721 |
| 46 | MP0003786_premature_aging | 1.53427541 |
| 47 | MP0002723_abnormal_immune_serum | 1.52949911 |
| 48 | MP0003718_maternal_effect | 1.52712911 |
| 49 | MP0009046_muscle_twitch | 1.51729248 |
| 50 | MP0002272_abnormal_nervous_system | 1.51507838 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.51500764 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.51417586 |
| 53 | MP0009764_decreased_sensitivity_to | 1.49795509 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.49169830 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.48739385 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.48487422 |
| 57 | MP0003329_amyloid_beta_deposits | 1.46507931 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.43677935 |
| 59 | MP0001819_abnormal_immune_cell | 1.43526661 |
| 60 | MP0004142_abnormal_muscle_tone | 1.42953684 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.40563057 |
| 62 | MP0000343_altered_response_to | 1.40184779 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.39876131 |
| 64 | MP0003690_abnormal_glial_cell | 1.39809773 |
| 65 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.39436430 |
| 66 | MP0002405_respiratory_system_inflammati | 1.38839034 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.38052771 |
| 68 | MP0002064_seizures | 1.37525719 |
| 69 | MP0004510_myositis | 1.37166247 |
| 70 | MP0000749_muscle_degeneration | 1.36370584 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33424500 |
| 72 | MP0002398_abnormal_bone_marrow | 1.31366238 |
| 73 | MP0008469_abnormal_protein_level | 1.30903374 |
| 74 | MP0010307_abnormal_tumor_latency | 1.30509448 |
| 75 | MP0002876_abnormal_thyroid_physiology | 1.30054512 |
| 76 | MP0004742_abnormal_vestibular_system | 1.29949769 |
| 77 | MP0005310_abnormal_salivary_gland | 1.28595159 |
| 78 | MP0004859_abnormal_synaptic_plasticity | 1.28325077 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.28212676 |
| 80 | MP0001764_abnormal_homeostasis | 1.27707357 |
| 81 | MP0004147_increased_porphyrin_level | 1.24390686 |
| 82 | MP0000716_abnormal_immune_system | 1.23520849 |
| 83 | * MP0000313_abnormal_cell_death | 1.23495298 |
| 84 | MP0002019_abnormal_tumor_incidence | 1.22701465 |
| 85 | MP0008569_lethality_at_weaning | 1.22155903 |
| 86 | MP0008932_abnormal_embryonic_tissue | 1.22152757 |
| 87 | MP0002396_abnormal_hematopoietic_system | 1.21401562 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.20054018 |
| 89 | MP0009745_abnormal_behavioral_response | 1.19762580 |
| 90 | MP0005330_cardiomyopathy | 1.19593237 |
| 91 | MP0001984_abnormal_olfaction | 1.19383340 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 1.18751478 |
| 93 | MP0001486_abnormal_startle_reflex | 1.18677879 |
| 94 | MP0000358_abnormal_cell_content/ | 1.17370729 |
| 95 | MP0002254_reproductive_system_inflammat | 1.16744173 |
| 96 | MP0003195_calcinosis | 1.16735247 |
| 97 | MP0005464_abnormal_platelet_physiology | 1.16135322 |
| 98 | MP0004924_abnormal_behavior | 1.15796405 |
| 99 | MP0005386_behavior/neurological_phenoty | 1.15796405 |
| 100 | MP0000490_abnormal_crypts_of | 1.15279778 |
| 101 | MP0000003_abnormal_adipose_tissue | 1.14638425 |
| 102 | MP0005451_abnormal_body_composition | 1.14629420 |
| 103 | MP0001968_abnormal_touch/_nociception | 1.13822702 |
| 104 | MP0003724_increased_susceptibility_to | 1.13284482 |
| 105 | MP0001501_abnormal_sleep_pattern | 1.12279344 |
| 106 | MP0002229_neurodegeneration | 1.12181370 |
| 107 | MP0003075_altered_response_to | 1.10238077 |
| 108 | MP0001853_heart_inflammation | 1.10223250 |
| 109 | MP0002067_abnormal_sensory_capabilities | 1.09607081 |
| 110 | MP0000703_abnormal_thymus_morphology | 1.09491892 |
| 111 | MP0005332_abnormal_amino_acid | 1.09182156 |
| 112 | MP0004215_abnormal_myocardial_fiber | 1.07797422 |
| 113 | MP0002736_abnormal_nociception_after | 1.06941782 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 1.06899262 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 1.06871544 |
| 116 | MP0008872_abnormal_physiological_respon | 1.06561288 |
| 117 | MP0005025_abnormal_response_to | 1.05010035 |
| 118 | MP0008775_abnormal_heart_ventricle | 1.03393848 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 1.02457372 |
| 120 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01588928 |
| 121 | MP0000015_abnormal_ear_pigmentation | 1.01250764 |
| 122 | MP0000751_myopathy | 1.00915116 |
| 123 | MP0009785_altered_susceptibility_to | 0.99122359 |
| 124 | * MP0002429_abnormal_blood_cell | 0.98373739 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.97251303 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.96887508 |
| 127 | MP0002970_abnormal_white_adipose | 0.96475349 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.96047993 |
| 129 | MP0005334_abnormal_fat_pad | 0.94703481 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.93600721 |
| 131 | MP0002722_abnormal_immune_system | 0.93548331 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.93251584 |
| 133 | MP0003186_abnormal_redox_activity | 0.92269210 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.91319138 |
| 135 | MP0003866_abnormal_defecation | 0.91095742 |
| 136 | MP0000604_amyloidosis | 0.89190401 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.88117165 |
| 138 | MP0000350_abnormal_cell_proliferation | 0.87903531 |
| 139 | MP0008260_abnormal_autophagy | 0.85651012 |
| 140 | MP0009115_abnormal_fat_cell | 0.85600221 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.82659365 |
| 142 | MP0002572_abnormal_emotion/affect_behav | 0.82028462 |
| 143 | MP0000747_muscle_weakness | 0.81863532 |
| 144 | MP0002163_abnormal_gland_morphology | 0.81722646 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.81661592 |
| 146 | MP0002972_abnormal_cardiac_muscle | 0.81484940 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.81249546 |
| 148 | MP0002118_abnormal_lipid_homeostasis | 0.81043756 |
| 149 | MP0005379_endocrine/exocrine_gland_phen | 0.81035185 |
| 150 | MP0002419_abnormal_innate_immunity | 0.81008138 |
| 151 | MP0006072_abnormal_retinal_apoptosis | 0.80725974 |
| 152 | MP0005410_abnormal_fertilization | 0.80064690 |
| 153 | MP0005319_abnormal_enzyme/_coenzyme | 0.80062083 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.77059974 |
| 155 | MP0009763_increased_sensitivity_to | 0.73948962 |
| 156 | MP0005647_abnormal_sex_gland | 0.73873914 |
| 157 | MP0002277_abnormal_respiratory_mucosa | 0.73665898 |
| 158 | MP0001919_abnormal_reproductive_system | 0.72659201 |
| 159 | MP0001727_abnormal_embryo_implantation | 0.71998457 |
| 160 | MP0001929_abnormal_gametogenesis | 0.70367112 |
| 161 | MP0005266_abnormal_metabolism | 0.70191199 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.69757605 |
| 163 | MP0008873_increased_physiological_sensi | 0.69579055 |
| 164 | MP0000371_diluted_coat_color | 0.67164097 |
| 165 | MP0005166_decreased_susceptibility_to | 0.66499566 |
| 166 | MP0002210_abnormal_sex_determination | 0.65604411 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.65290847 |
| 168 | MP0004947_skin_inflammation | 0.64755806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 4.69758183 |
| 2 | Hepatic necrosis (HP:0002605) | 4.62862977 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.48668037 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.42655327 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.19671691 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 4.18558300 |
| 7 | Increased muscle lipid content (HP:0009058) | 4.16529322 |
| 8 | Acute encephalopathy (HP:0006846) | 4.04604098 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.97761288 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.93226371 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.93226371 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.93226371 |
| 13 | * Increased CSF lactate (HP:0002490) | 3.61346729 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.59817988 |
| 15 | Increased serum pyruvate (HP:0003542) | 3.58725293 |
| 16 | Abnormality of glycolysis (HP:0004366) | 3.58725293 |
| 17 | Progressive macrocephaly (HP:0004481) | 3.53448716 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 3.42978149 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40815247 |
| 20 | Myoglobinuria (HP:0002913) | 3.35925730 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.26545536 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.26545536 |
| 23 | Abnormality of alanine metabolism (HP:0010916) | 3.24615876 |
| 24 | Hyperalaninemia (HP:0003348) | 3.24615876 |
| 25 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.24615876 |
| 26 | Microvesicular hepatic steatosis (HP:0001414) | 3.24110423 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.23412597 |
| 28 | IgM deficiency (HP:0002850) | 3.21537612 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.20857163 |
| 30 | * Lactic acidosis (HP:0003128) | 3.20160608 |
| 31 | Hyperglycinuria (HP:0003108) | 3.15515433 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.08585028 |
| 33 | Recurrent sinusitis (HP:0011108) | 3.07766400 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 2.96190432 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96190432 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 2.92638918 |
| 37 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.89708934 |
| 38 | Exercise-induced myalgia (HP:0003738) | 2.89678626 |
| 39 | Neuroendocrine neoplasm (HP:0100634) | 2.87029884 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.87026455 |
| 41 | Leukodystrophy (HP:0002415) | 2.82813339 |
| 42 | Oligomenorrhea (HP:0000876) | 2.79488110 |
| 43 | Pheochromocytoma (HP:0002666) | 2.79148022 |
| 44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.74957645 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.72672416 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.71200565 |
| 47 | Respiratory failure (HP:0002878) | 2.71072569 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.69966302 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69966302 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.68805523 |
| 51 | Cerebral edema (HP:0002181) | 2.68691363 |
| 52 | Multiple enchondromatosis (HP:0005701) | 2.67733116 |
| 53 | Increased serum lactate (HP:0002151) | 2.66973509 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.64732204 |
| 55 | Colitis (HP:0002583) | 2.62690787 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.62236040 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.61661044 |
| 58 | Progressive inability to walk (HP:0002505) | 2.61069918 |
| 59 | IgG deficiency (HP:0004315) | 2.59459917 |
| 60 | Chromsome breakage (HP:0040012) | 2.55640689 |
| 61 | Petechiae (HP:0000967) | 2.54349801 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.54062809 |
| 63 | Chronic otitis media (HP:0000389) | 2.53579480 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52115881 |
| 65 | Reticulocytopenia (HP:0001896) | 2.51888968 |
| 66 | Type I transferrin isoform profile (HP:0003642) | 2.50151724 |
| 67 | Renal Fanconi syndrome (HP:0001994) | 2.49744046 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.49592505 |
| 69 | Lymphopenia (HP:0001888) | 2.49023372 |
| 70 | Exercise intolerance (HP:0003546) | 2.47185069 |
| 71 | Obstructive lung disease (HP:0006536) | 2.46919599 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46919599 |
| 73 | Tinnitus (HP:0000360) | 2.43493576 |
| 74 | Birth length less than 3rd percentile (HP:0003561) | 2.42787045 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.41168376 |
| 76 | Focal motor seizures (HP:0011153) | 2.40470030 |
| 77 | Agnosia (HP:0010524) | 2.39065891 |
| 78 | Methylmalonic aciduria (HP:0012120) | 2.38706829 |
| 79 | Papilloma (HP:0012740) | 2.38055330 |
| 80 | Verrucae (HP:0200043) | 2.38055330 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.37665694 |
| 82 | Optic disc pallor (HP:0000543) | 2.35889738 |
| 83 | Chronic sinusitis (HP:0011109) | 2.35820194 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35335636 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.34600925 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.33507283 |
| 87 | Recurrent viral infections (HP:0004429) | 2.33175036 |
| 88 | Nausea (HP:0002018) | 2.30446964 |
| 89 | Aplastic anemia (HP:0001915) | 2.29571975 |
| 90 | IgA deficiency (HP:0002720) | 2.29490431 |
| 91 | Recurrent abscess formation (HP:0002722) | 2.28849597 |
| 92 | Increased serum ferritin (HP:0003281) | 2.27849725 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.27810715 |
| 94 | Pancytopenia (HP:0001876) | 2.25561265 |
| 95 | Stomatitis (HP:0010280) | 2.24931189 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23075828 |
| 97 | Thyroid-stimulating hormone excess (HP:0002925) | 2.21924516 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.20350651 |
| 99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15337366 |
| 100 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15337366 |
| 101 | Abnormal protein glycosylation (HP:0012346) | 2.15337366 |
| 102 | Abnormal glycosylation (HP:0012345) | 2.15337366 |
| 103 | Cerebral hypomyelination (HP:0006808) | 2.15076417 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.13808674 |
| 105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.12571508 |
| 106 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.12571508 |
| 107 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12556417 |
| 108 | Abnormality of chromosome stability (HP:0003220) | 2.11988891 |
| 109 | Meckel diverticulum (HP:0002245) | 2.11772762 |
| 110 | Sensory axonal neuropathy (HP:0003390) | 2.11445962 |
| 111 | Respiratory difficulties (HP:0002880) | 2.11276293 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 2.10619211 |
| 113 | Combined immunodeficiency (HP:0005387) | 2.10194523 |
| 114 | CNS demyelination (HP:0007305) | 2.09982576 |
| 115 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.09862413 |
| 116 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.09175095 |
| 117 | Mutism (HP:0002300) | 2.07974553 |
| 118 | Central scotoma (HP:0000603) | 2.07667670 |
| 119 | Loss of speech (HP:0002371) | 2.07411604 |
| 120 | Recurrent fungal infections (HP:0002841) | 2.06333485 |
| 121 | Bone marrow hypocellularity (HP:0005528) | 2.05663946 |
| 122 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05553892 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 2.03619856 |
| 124 | Methylmalonic acidemia (HP:0002912) | 2.02868075 |
| 125 | Hyperventilation (HP:0002883) | 2.01297984 |
| 126 | Hypertensive crisis (HP:0100735) | 2.00466871 |
| 127 | Hepatosplenomegaly (HP:0001433) | 2.00431868 |
| 128 | Abnormality of the ileum (HP:0001549) | 1.99754996 |
| 129 | Abnormality of B cell number (HP:0010975) | 1.99498006 |
| 130 | B lymphocytopenia (HP:0010976) | 1.99498006 |
| 131 | Congenital stationary night blindness (HP:0007642) | 1.99401550 |
| 132 | Poor head control (HP:0002421) | 1.99122581 |
| 133 | Recurrent pneumonia (HP:0006532) | 1.98215707 |
| 134 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.97997487 |
| 135 | Emphysema (HP:0002097) | 1.97462003 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 1.96948012 |
| 137 | * Lethargy (HP:0001254) | 1.96851514 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.96601174 |
| 139 | Abnormality of the anterior horn cell (HP:0006802) | 1.96280839 |
| 140 | Degeneration of anterior horn cells (HP:0002398) | 1.96280839 |
| 141 | Neutropenia (HP:0001875) | 1.94294716 |
| 142 | Abnormal trabecular bone morphology (HP:0100671) | 1.94231946 |
| 143 | Emotional lability (HP:0000712) | 1.93239982 |
| 144 | Meningitis (HP:0001287) | 1.92718168 |
| 145 | Leukopenia (HP:0001882) | 1.92682615 |
| 146 | Hypomagnesemia (HP:0002917) | 1.92423716 |
| 147 | Exertional dyspnea (HP:0002875) | 1.90956214 |
| 148 | Cellulitis (HP:0100658) | 1.90229452 |
| 149 | Albinism (HP:0001022) | 1.89201305 |
| 150 | Cerebral hemorrhage (HP:0001342) | 1.88181705 |
| 151 | Rough bone trabeculation (HP:0100670) | 1.87583032 |
| 152 | Muscle stiffness (HP:0003552) | 1.87503361 |
| 153 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87472528 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.86997401 |
| 155 | Glycosuria (HP:0003076) | 1.86997401 |
| 156 | Neoplasm of head and neck (HP:0012288) | 1.86802430 |
| 157 | Esophageal neoplasm (HP:0100751) | 1.86802430 |
| 158 | Increased IgM level (HP:0003496) | 1.86690105 |
| 159 | Hyperammonemia (HP:0001987) | 1.85726824 |
| 160 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85527098 |
| 161 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85527098 |
| 162 | Recurrent otitis media (HP:0000403) | 1.83845704 |
| 163 | Myokymia (HP:0002411) | 1.81158599 |
| 164 | Abnormality of magnesium homeostasis (HP:0004921) | 1.80469298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.73474632 |
| 2 | VRK2 | 3.41803587 |
| 3 | CDC7 | 3.13519253 |
| 4 | PDK3 | 3.07514959 |
| 5 | PDK4 | 3.07514959 |
| 6 | BCKDK | 3.07346940 |
| 7 | OXSR1 | 3.01118577 |
| 8 | PBK | 2.68212327 |
| 9 | BLK | 2.24106760 |
| 10 | SYK | 2.10393138 |
| 11 | SRPK1 | 2.08512596 |
| 12 | CSF1R | 2.07750201 |
| 13 | STK39 | 2.05332127 |
| 14 | ZAK | 2.05226608 |
| 15 | CDK19 | 2.04285652 |
| 16 | PIM2 | 1.94140686 |
| 17 | PRKCH | 1.72995616 |
| 18 | MATK | 1.72916509 |
| 19 | PINK1 | 1.68704456 |
| 20 | TTK | 1.62997867 |
| 21 | VRK1 | 1.62802183 |
| 22 | MAP3K13 | 1.51017496 |
| 23 | TSSK6 | 1.50696654 |
| 24 | PDK2 | 1.49975775 |
| 25 | TLK1 | 1.49775030 |
| 26 | PLK4 | 1.48592009 |
| 27 | CAMK1D | 1.46927477 |
| 28 | WNK4 | 1.46387432 |
| 29 | BMPR2 | 1.42096551 |
| 30 | BUB1 | 1.41895496 |
| 31 | ARAF | 1.41793917 |
| 32 | CASK | 1.40960852 |
| 33 | LMTK2 | 1.40128403 |
| 34 | JAK3 | 1.39021795 |
| 35 | MAP3K14 | 1.37643042 |
| 36 | MAP3K11 | 1.37638590 |
| 37 | PHKG1 | 1.37369350 |
| 38 | PHKG2 | 1.37369350 |
| 39 | PRPF4B | 1.36648101 |
| 40 | BTK | 1.35145799 |
| 41 | CCNB1 | 1.33588452 |
| 42 | IRAK4 | 1.33202747 |
| 43 | KIT | 1.32626400 |
| 44 | NME2 | 1.31272078 |
| 45 | ABL2 | 1.30562468 |
| 46 | NUAK1 | 1.29874033 |
| 47 | OBSCN | 1.28045319 |
| 48 | NEK1 | 1.27379865 |
| 49 | PKN1 | 1.24402879 |
| 50 | PRKCQ | 1.18918205 |
| 51 | CDK4 | 1.17976270 |
| 52 | MAP2K7 | 1.17279702 |
| 53 | ATR | 1.16208255 |
| 54 | SGK223 | 1.15438092 |
| 55 | SGK494 | 1.15438092 |
| 56 | FES | 1.14846145 |
| 57 | PDK1 | 1.13869364 |
| 58 | SIK3 | 1.11946491 |
| 59 | EIF2AK1 | 1.11806863 |
| 60 | ACVR1B | 1.11608996 |
| 61 | JAK1 | 1.10868130 |
| 62 | SIK2 | 1.10373086 |
| 63 | TXK | 1.08417925 |
| 64 | CHEK2 | 1.07415752 |
| 65 | GRK5 | 1.06347460 |
| 66 | LYN | 1.04800456 |
| 67 | CSNK1G3 | 1.04238015 |
| 68 | PLK1 | 1.03948379 |
| 69 | GRK7 | 1.03097784 |
| 70 | NME1 | 1.02723928 |
| 71 | MAP2K3 | 1.01897734 |
| 72 | SMG1 | 1.01623240 |
| 73 | DAPK1 | 0.98705669 |
| 74 | KDR | 0.96728294 |
| 75 | WEE1 | 0.94575405 |
| 76 | RIPK4 | 0.92855800 |
| 77 | GRK6 | 0.92559083 |
| 78 | TNIK | 0.90806681 |
| 79 | TAOK2 | 0.88582182 |
| 80 | BRAF | 0.87802952 |
| 81 | PTK2B | 0.85982639 |
| 82 | IKBKB | 0.84882438 |
| 83 | TAOK3 | 0.84866688 |
| 84 | AURKA | 0.84492229 |
| 85 | MAP3K8 | 0.82311596 |
| 86 | TRIM28 | 0.81523852 |
| 87 | CAMK1G | 0.81513313 |
| 88 | STK16 | 0.78340978 |
| 89 | TESK2 | 0.78161764 |
| 90 | LCK | 0.76241369 |
| 91 | PIM1 | 0.76161882 |
| 92 | CSNK1G1 | 0.75762467 |
| 93 | PLK3 | 0.74968688 |
| 94 | TRIB3 | 0.74160309 |
| 95 | SGK2 | 0.73602939 |
| 96 | AURKB | 0.73135825 |
| 97 | CHEK1 | 0.72970586 |
| 98 | RPS6KB2 | 0.72952210 |
| 99 | EIF2AK3 | 0.72700455 |
| 100 | TBK1 | 0.71821077 |
| 101 | MAPK11 | 0.71780835 |
| 102 | PAK6 | 0.70210770 |
| 103 | PDPK1 | 0.69628260 |
| 104 | STK4 | 0.68129813 |
| 105 | SIK1 | 0.67902638 |
| 106 | SGK3 | 0.65558154 |
| 107 | CLK1 | 0.65177100 |
| 108 | EPHB1 | 0.64477097 |
| 109 | WNK1 | 0.64462590 |
| 110 | CDK7 | 0.63171647 |
| 111 | RPS6KA5 | 0.62114694 |
| 112 | STK24 | 0.61784748 |
| 113 | CSNK1G2 | 0.61264353 |
| 114 | MAPK12 | 0.60727050 |
| 115 | ALK | 0.60667594 |
| 116 | PRKAA2 | 0.59614452 |
| 117 | MAP3K7 | 0.59183981 |
| 118 | ZAP70 | 0.58270626 |
| 119 | CSNK2A1 | 0.57837058 |
| 120 | IRAK3 | 0.57807822 |
| 121 | RPS6KA4 | 0.55239919 |
| 122 | BRSK2 | 0.55055434 |
| 123 | CSNK1A1L | 0.54206338 |
| 124 | EIF2AK2 | 0.51195455 |
| 125 | MARK3 | 0.51015145 |
| 126 | MAPKAPK3 | 0.49591759 |
| 127 | MST4 | 0.49190036 |
| 128 | MKNK1 | 0.49109867 |
| 129 | TEC | 0.48580989 |
| 130 | TGFBR1 | 0.47986960 |
| 131 | CDK5 | 0.47924174 |
| 132 | MAPK7 | 0.47272453 |
| 133 | CDK8 | 0.46687982 |
| 134 | CSNK2A2 | 0.45920802 |
| 135 | STK10 | 0.45731213 |
| 136 | TYK2 | 0.45338892 |
| 137 | MAP2K6 | 0.45066829 |
| 138 | CAMK1 | 0.45035465 |
| 139 | ATM | 0.44994153 |
| 140 | MAP4K2 | 0.44168437 |
| 141 | ERN1 | 0.43260868 |
| 142 | HCK | 0.42183597 |
| 143 | IKBKE | 0.41898904 |
| 144 | ADRBK2 | 0.40856324 |
| 145 | PRKCD | 0.40520929 |
| 146 | PRKD2 | 0.40379607 |
| 147 | TNK2 | 0.39916440 |
| 148 | GRK1 | 0.39507185 |
| 149 | ITK | 0.39437444 |
| 150 | FGR | 0.39310330 |
| 151 | MAPKAPK5 | 0.38986732 |
| 152 | LIMK1 | 0.38312348 |
| 153 | JAK2 | 0.37807371 |
| 154 | CDK3 | 0.37770798 |
| 155 | RAF1 | 0.37302210 |
| 156 | BMPR1B | 0.37253159 |
| 157 | BCR | 0.37244343 |
| 158 | PAK1 | 0.37180091 |
| 159 | WNK3 | 0.36572978 |
| 160 | CHUK | 0.36154775 |
| 161 | BRSK1 | 0.35491940 |
| 162 | MAP3K12 | 0.35428179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.19621199 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.06017425 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.64674511 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.49097794 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.40064060 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.27600892 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.01229679 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78247907 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.48718485 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.38506869 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26209978 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.25267153 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.24222588 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23514937 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.11710086 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.08859468 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02042002 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.93078543 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.92251256 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.86860723 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.82849270 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78399178 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70026641 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68994801 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.65223956 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62985800 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60111460 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56992199 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.53262947 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.42949708 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42741591 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.40273575 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35659736 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32197977 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30903707 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30092985 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28875652 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23370117 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.23167458 |
| 40 | Proteasome_Homo sapiens_hsa03050 | 1.22509337 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17778900 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14858581 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14723091 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13176788 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.12824352 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11737904 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11310149 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.10152201 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09745523 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04624788 |
| 51 | Cell cycle_Homo sapiens_hsa04110 | 1.03012227 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01526647 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00953095 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00775648 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99942539 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.99911918 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98376244 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98143856 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.97274745 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96721614 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95643064 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95242437 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93767817 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92724602 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88171638 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.83563976 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83098098 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82985394 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.82069591 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82063388 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82052767 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71680656 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69199119 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69107088 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68918416 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68704773 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68152763 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66835843 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66571689 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66368174 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65383799 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.64401848 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.63861975 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63704250 |
| 85 | Ribosome_Homo sapiens_hsa03010 | 0.60445520 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59319178 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58847800 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57485493 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57350301 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56379430 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.55362778 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.53514767 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52854173 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51328797 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51171613 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.50739156 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.49814249 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.48451534 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.48081620 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47951189 |
| 101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47415642 |
| 102 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46893935 |
| 103 | DNA replication_Homo sapiens_hsa03030 | 0.46469665 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46131842 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45887366 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.45776672 |
| 107 | Mismatch repair_Homo sapiens_hsa03430 | 0.45165972 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44976784 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44592784 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42895776 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42035975 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.41991834 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41899681 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41768542 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41599315 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41572158 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.41279502 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41134184 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40972838 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40838894 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40640139 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.40149557 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.40052828 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38476724 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38054998 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.37284248 |
| 127 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.36873976 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36461042 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36134556 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35941937 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35890721 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35720336 |
| 133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32961254 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30494514 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30263644 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30214305 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29876360 |
| 138 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29809552 |
| 139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29743638 |
| 140 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29456761 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28270541 |
| 142 | Taste transduction_Homo sapiens_hsa04742 | 0.26606555 |
| 143 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25939958 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23994300 |
| 145 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22002938 |
| 146 | Long-term depression_Homo sapiens_hsa04730 | 0.20665257 |
| 147 | Measles_Homo sapiens_hsa05162 | 0.20263364 |
| 148 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19807255 |
| 149 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18051381 |
| 150 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18047551 |
| 151 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.17206506 |
| 152 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.16739767 |
| 153 | RNA degradation_Homo sapiens_hsa03018 | 0.15871125 |
| 154 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15393856 |
| 155 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15136389 |

